Last Update Time:
13-Mar-2025 11:47:47
ISIN:
INE878I01022
Sector:
Healthcare
Symbol:
BAFNAPH
Bafna Pharmaceuticals Limited
₹82.00
₹0.74
(0.91%)
▲
Prev. Close
₹81.26
Open
₹81.26
Close
₹0.00
Range
₹77.90 - ₹86.10
High
₹82.00
Low
₹81.00
Ind. Close
₹0.00
VWAP
₹81.29
The current stock price of Bafna Pharmaceuticals Limited is ₹82.00, with a target price range between ₹77.90 and ₹86.10. The stock has experienced a price change of ₹0.74 (0.91%), reflecting recent market volatility.
Today's opening price was ₹81.26, while the previous close stood at ₹81.26.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Bafna Pharmaceuticals Limited Price Chart
Bafna Pharmaceuticals Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 81.26
- Change: -81.26%
- Total Traded Volume: 0
- Total Buy Quantity: 200
- Total Sell Quantity: 713
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
| 77.19 | 100.00 | 0.00 |
| 78.00 | 100.00 | 0.00 |
| 82.50 | 0.00 | 258.00 |
| 82.60 | 0.00 | 50.00 |
| 83.90 | 0.00 | 100.00 |
| 85.00 | 0.00 | 205.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 205
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 82.00 | 6 | 82.48 | 100 |
| 80.50 | 250 | 82.49 | 50 |
| 78.53 | 50 | 82.50 | 258 |
| 78.52 | 500 | 83.90 | 200 |
| 78.50 | 50 | 84.80 | 30 |
Total Buy Quantity: 200
Total Sell Quantity: 713
Shareholding Patterns of Bafna Pharmaceuticals Limited
Key Trade Statistics of Bafna Pharmaceuticals Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.01 |
| Traded Value (₹ Cr.) | 0.01 |
| Total Market Cap (₹ Cr.) | 193.98 |
| Free Float Market Cap (₹ Cr.) | 22.69 |
| Impact cost | 2.29 |
| Quantity Traded | N/A |
| Deliverable Quantity | N/A |
| % of Quantity to Traded | N/A |
| Security VaR | N/A |
| Index VaR | N/A |
| VaR Margin | 100 |
| Extreme Loss Rate | N/A |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 100 |
| Face Value | 10 |
Key Price Statistics of Bafna Pharmaceuticals Limited
The 52-week high for Bafna Pharmaceuticals Limited was ₹113.00, recorded on 07-May-2024. On the other hand, the 52-week low stands at ₹69.00, with the lowest value recorded on 19-Feb-2025.
The upper band for trading is ₹85.32, and the lower band is ₹77.19. The price band is 5%.
The stock's daily volatility stands at 2.80, while the annualized volatility is 53.49. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (07-May-2024) | 113.00 |
| 52 Week Low (19-Feb-2025) | 69.00 |
| Upper Band | 85.32 |
| Lower Band | 77.19 |
| Price Band (%) | 5 |
| Daily Volatility | 2.80 |
| Annualised Volatility | 53.49 |
| Tick Size | 0.01 |
Key Securities Statistics of Bafna Pharmaceuticals Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 27-Feb-2020 |
| Adjusted P/E | 41.31 |
| Symbol P/E | 44.74 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Bafna Pharmaceuticals Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Bafna Pharmaceuticals Limited
| Subject | Date |
|---|---|
| Copy of Newspaper Publication | 11-Feb-2025 |
| Integrated Filing- Financial | 06-Feb-2025 |
| Outcome of Board Meeting | 06-Feb-2025 |
| Financial Result Updates | 06-Feb-2025 |
| Board Meeting Intimation | 28-Jan-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 09-Jan-2025 |
| Trading Window-XBRL | 25-Dec-2024 |
| Trading Window | 25-Dec-2024 |
Corporate Actions of Bafna Pharmaceuticals Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 17-Sep-2024 |
| 10 | Annual General Meeting | 20-Jul-2022 |
| 10 | Annual General Meeting | 05-Aug-2021 |
| 10 | Annual General Meeting | 23-Jul-2020 |
Board Meetings of Bafna Pharmaceuticals Limited
Financial Results of Bafna Pharmaceuticals Limited
Company Directory of Bafna Pharmaceuticals Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Registered Office | No.299 Thambu Chetty Street, Chennai | CHENNAI |
Insider Trading of Bafna Pharmaceuticals Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | SRJR LIFESCIENCES LLP | 916568 | Sell |
| 7(2) | SRJR LIFESCIENCES LLP | 1083892 | Sell |
| 7(2) | SRJR LIFESCIENCES LLP | 3348636 | Sell |
| 7(2) | SRJR LIFESCIENCES LLP | 1668145 | Sell |
| 7(2) | SRJR LIFESCIENCES LLP | 1368129 | Sell |
| 7(2) | SRJR LIFESCIENCES LLP | 1750345 | Sell |
| 7(2) | MAHAVEER CHAND BAFNA HUF | 0 | Pledge Invoke |
| 7(2) | MAHAVEER CHAND BAFNA | 0 | Pledge Invoke |
| 7(2) | PARAS BAFNA | 0 | Pledge Invoke |
| 7(2) | SASIKALA BAFNA | 0 | Pledge Invoke |
| 7(2) | AMRIBAI BAFNA | 0 | Pledge Invoke |
| 7(2) | Chetna Bafna | 0 | Sell |
| 7(2) | SRJR Lifesciences LLP | 553558226 | Buy |
Annual Reports of Bafna Pharmaceuticals Limited
Investor Complaints of Bafna Pharmaceuticals Limited
Event Calendar of Bafna Pharmaceuticals Limited
| Purpose | Details |
|---|---|
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
| Other business matters | Bafna Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 21-Mar-2022 to consider resignation and appointment of Company Secretary and Compliance officer of the Company and any other business matters with the permission of Chair. |
| Financial results | Bafna Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 11-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Bafna Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider the un audited results for the Half year and Quarter ended period ended 30th September 2022 |
| Financial Results | To consider and approve the Unaudited financial results for the Nine Months period and Quarter ended December 31, 2022 |
| Other business matters | To Consider The Appointment Of Company Secretary Cum Compliance Officer And Any Other Business With The Permission Of The Chair |
| Financial Results | BAFNAPH : 27-May-2023 : The Company has informed the Exchange that a Board meeting to be held on May 24, 2023 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 27, 2023, To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Other business matters | To consider and approve the appointment of 1. Mr. Vinayak Dinesh Dendukuri (DIN: 07601309) as Additional Director designated as Whole-time Director Operation.2. Mr. Upendar Mekala Reddy (DIN: 08898174) as Additional Director designated as Non-Executive Non-independent Director;3. Mr. Krishna Yeachuri (DIN: 00066898) as Additional Director designated as Non-Executive Independent Director, and any other business with the permission of the Chair. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the un-audited financial results for the period ended December 31, 2023 |
| Financial Results | To consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2024 |
| Financial Results | To consider and approve the Unaudited financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the Unaudited Financial Results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the unaudited financial results for the period ended December 31, 2024 |
Share Transfers of Bafna Pharmaceuticals Limited
Voting Results of Bafna Pharmaceuticals Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 25-SEP-2024 | AGM | Adoption of Audited Financial Statements of the Company for the financialnyear ended March 31, 2024, together with the Reports of the Board ofnDirectors and Auditor￢ﾀﾙs thereon. |
| 25-SEP-2024 | AGM | Ratification of Remuneration of Cost Auditors M/s. N Sivashankaran andnCo., Cost Accountants (ICMAI FRN. 100662) for the F.Y 2024-25. |
| 25-SEP-2024 | AGM | Sale / Disposal of Manufacturing Unit of the Company located at Madhavaram, Chennai, Tamil Nadu |
| 25-SEP-2024 | AGM | Re-appointment of Ms. Shanmugam Hemalatha (DIN: 02714329), as Whole-nTime Director of the Company, for a period of 5 years |
| 25-SEP-2024 | AGM | Re-appointment of Mr. Upendar Mekala Reddy (DIN: 08898174), as Director ofnthe Company, who retires by rotation and being eligible, offers himself fornre-appointment. |
| 22-SEP-2023 | AGM | Adoption of Financial Statements:To receive, consider and adopt the Audited financial statements of the Company for the financial year ended March 31, 2023, the Reports of the board of Directors￢ﾀﾙ and Auditor￢ﾀﾙs thereon. |
| 22-SEP-2023 | AGM | Appointment of Mr Krishna Yeachuri (DIN: 00066898) as a Non executive Independent Director of the Company |
| 22-SEP-2023 | AGM | Appointment of MR Upendar Mekala Redday (DIN :08898174) as a Non-executive Director of the Company |
| 22-SEP-2023 | AGM | Appointment of Shri Vinayak Dinesh Dendukuri (DIN: 07601309) as a Director and Whole-time Director |
| 22-SEP-2023 | AGM | To appoint M/s N Sivashankaran & Co., Cost Accountant as cost auditor of the Company and to fix their remuneration. |
| 22-SEP-2023 | AGM | To appoint Mrs. Akila Chintalapati Raju (DIN: 07590312) as director liable to retire by rotation and being eligible offers herself for re-appointment. |
| 28-JUL-2022 | AGM | Adoption of Financial Statements for the financial year ended March 31, 2022 |
| 28-JUL-2022 | AGM | To ratify the remuneration payable to M/s Sivashankaran and Co, Cost Auditor for the year 2022 -2023 |
| 28-JUL-2022 | AGM | To appoint M/s BRAHMAYYA & Co, Chartered Accountants as statutory auditors of the Company and to fix their remuneration |
| 28-JUL-2022 | AGM | To appoint Mrs. Akila Chintalapati Raju (DIN: 07590312) as director liable to retire by rotation and being eligible offers himself for re appointment |
| 14-AUG-2021 | AGM | Adoption of Financial Statements |
| 14-AUG-2021 | AGM | Regularisation of appointment of Mr. Atul Sachdeva (DIN:07645130) as a Director (Non Executive and Non- Independent) |
| 14-AUG-2021 | AGM | Regularisation of appointment of Mrs. Ravichandran Chitra (DIN:07749125) as an Independent Non Executive Director |
| 14-AUG-2021 | AGM | Regularisation of appointment of Mrs. Akila C Raju (DIN:07590312) as a Director (Non Executive and Non- Independent) |
| 14-AUG-2021 | AGM | Regularisation of appointment of Ms. S.Hemalatha (DIN:02714329) as Whole-Time Director |
FAQs on Bafna Pharmaceuticals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.